首頁 > 市場調查報告書 > 醫療設備

e保健體外診斷藥物開發人工智能人工智能藥物研發診斷用人工智能

市場調查報告書

商品編碼

1824565

2025年全球AI癌症診斷市場報告

AI In Cancer Diagnostics Global Market Report 2025

出版日期: 2025年09月10日 | 出版商:

The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年，基於人工智慧的癌症診斷市場將呈指數級成長，到2029年將達到16.5億美元，複合年成長率為20.0%。預測期內的成長歸因於可解釋人工智慧的興起、全球醫療保健支出的成長、與電子健康記錄(EHR) 的整合、個人化醫療的普及以及人工智慧演算法的持續進步。預測期內的主要趨勢包括成像技術的進步、技術融合、醫療保健公司與科技公司之間的合作、數位病理學的興起以及組織病理學檢測的自動化。

未來五年20.0%的成長率預測較先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國市場的發展，因為這將提高來自英國和加拿大的人工智慧組織病理學掃描儀和基因組分析軟體的成本，減緩精準腫瘤學的普及，並增加病理學實驗室的支出。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

癌症發生率的上升預計將推動人工智慧在癌症診斷市場的成長。癌症是指一組以異常細胞生長為特徵的疾病，這些細胞會侵襲並轉移到身體的其他部位。人工智慧在癌症治療中的應用旨在提高效率、準確性和個人化治療方案，最終改善癌症患者的預後。例如，美國政府機構國家癌症研究所在 2024 年 5 月預測，2024 年美國將診斷出約 200 萬例新癌症病例，導致超過 611,000 人死亡。到 2040 年，全球新癌症病例預計將增加到 2,990 萬例，癌症相關死亡人數將達到 1,530 萬例。因此，癌症發生率的上升正在推動人工智慧在癌症診斷市場的應用。

全球人工智慧癌症診斷：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
最終用途產業分析
全球基於人工智慧的癌症診斷市場：成長率分析
全球基於人工智慧的癌症診斷市場表現：規模與成長，2019-2024
全球基於人工智慧的癌症診斷市場預測：規模與成長，2024-2029 年，2034 年
全球基於人工智慧的癌症診斷：總潛在市場（TAM）

第6章市場細分

全球基於人工智慧的癌症診斷市場：按組成部分、表現和預測，2019-2024 年、2024-2029 年、2034 年
軟體解決方案
硬體
服務
全球人工智慧癌症診斷市場（按癌症類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
乳癌
肺癌
腦腫瘤
皮膚癌和子宮頸癌
攝護腺癌和結腸癌
其他類型的癌症
全球基於人工智慧的癌症診斷市場：按應用、表現和預測，2019-2024 年、2024-2029 年、2034 年
篩檢和診斷
腫瘤識別
監控
全球基於人工智慧的癌症診斷市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
醫院
診斷中心
醫學研究所
合約研究組織
全球基於人工智慧的癌症診斷市場：按軟體解決方案（類型）、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
機器學習軟體
深度學習軟體
影像分析軟體
全球基於人工智慧的癌症診斷市場：按硬體（類型）細分、效能和預測，2019-2024 年、2024-2029 年、2034 年
人工智慧成像系統
診斷設備
全球基於人工智慧的癌症診斷市場：按服務類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
人工智慧整合服務
諮詢和培訓服務
支援和維護服務

第7章區域和國家分析

全球基於人工智慧的癌症診斷市場：按地區、表現和預測，2019-2024 年、2024-2029 年、2034 年
全球基於人工智慧的癌症診斷市場：按國家/地區、表現和預測，2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章：澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

基於人工智慧的癌症診斷市場：競爭格局
基於人工智慧的癌症診斷市場：公司簡介
- Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
- Tempus Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

Guardant Health
Lunit Inc.
Paige AI Inc.
Ada Health GmbH
Viz.ai Inc.
Butterfly Network Inc.
Insilico Medicine
BenevolentAI SA SA
Enlitic Inc.
Ibex Medical Analytics
Kheiron Medical Technologies Limited
CureMetrix Inc.
CancerIQ Inc.
MultiplAI Health
Freenome Holdings Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

2029 年人工智慧癌症診斷市場：提供新機會的國家
2029年基於人工智慧的癌症診斷市場：細分領域將帶來新機會
2029年基於人工智慧的癌症診斷市場：成長策略
- 基於市場趨勢的策略
- 競爭對手策略

第36章附錄

簡介目錄

Product Code: r27273u

AI in cancer diagnostics involves employing artificial intelligence technologies such as machine learning and deep learning to analyze medical images, genetic data, or patient histories for aiding in the early detection, diagnosis, and prognosis of cancer. These systems can detect patterns and anomalies in data that may elude human perception, thereby enhancing diagnostic accuracy and efficiency.

The primary components of AI in cancer diagnostics include software solutions, hardware, and services. Software solutions utilize artificial intelligence (AI) and machine learning (ML) technologies to enhance the accuracy and efficiency of cancer detection, prognosis, and treatment selection. Various types of cancer, including breast cancer, lung cancer, brain tumors, skin cancer, cervical cancer, prostate cancer, colorectal cancer, and others, are addressed. These applications encompass screening and diagnosis, tumor identification, and monitoring, and are utilized by a range of end-users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The AI in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in cancer diagnostics market statistics, including AI in cancer diagnostics industry global market size, regional shares, competitors with an AI in cancer diagnostics market share, detailed AI in cancer diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in cancer diagnostics industry. This AI in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ai in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.66 billion in 2024 to $0.79 billion in 2025 at a compound annual growth rate (CAGR) of 21.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, data explosion in healthcare, supportive regulatory environment, focus on precision medicine, expansion of AI applications beyond imaging.

The ai in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.65 billion in 2029 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to emergence of explainable AI, global increase in healthcare it spending, integration with electronic health records (EHR), personalized medicine adoption, continued advances in AI algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, rise of digital pathology, automation in histopathology.

The forecast of 20.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of AI-powered histopathology scanners and genomic analysis software sourced from the UK and Canada, thereby slowing precision oncology adoption and elevating pathology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cancer is expected to drive the growth of artificial intelligence in the cancer diagnostics market. Cancer refers to a group of diseases characterized by abnormal cell growth that can invade or spread to other parts of the body. The integration of AI in cancer care aims to improve efficiency, accuracy, and personalized treatment options, ultimately enhancing outcomes for cancer patients. For example, in May 2024, the National Cancer Institute, a US-based government agency, projected that approximately 2 million new cancer cases would be diagnosed in the U.S. in 2024, with over 611,000 deaths expected. By 2040, global new cancer cases are anticipated to rise to 29.9 million, with cancer-related deaths reaching 15.3 million. As a result, the growing prevalence of cancer is driving the adoption of artificial intelligence in the cancer diagnostics market.

Leading companies in the AI in cancer diagnostics market are experiencing notable growth driven by advancements in AI-powered digital pathology solutions for cancer diagnosis. These solutions utilize AI algorithms to detect cancer and other diagnostic features in various tissue types, offering accurate and timely cancer diagnosis, supporting case prioritization, and ensuring reproducible diagnoses. For instance, in November 2023, Dedalus & Ibex Medical Analytics introduced an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to enhance accuracy, provide AI-powered decision support tools, streamline reporting, improve laboratory efficiency, and boost diagnostic confidence.

In December 2023, Lunit, a South Korean AI company, acquired Volpara for $193 million, aiming to establish the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market. Volpara's extensive presence in over 2,000 medical sites across the U.S. and its vast database of over 100 million high-quality mammogram images position it as a valuable addition to Lunit's capabilities. Volpara, based in New Zealand, specializes in providing AI-powered software for personalized screening and early detection of breast cancer.

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the AI in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Software Solutions; Hardware; Services
2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types
3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring
4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations
Subsegments:
1) By Software Solutions: Machine Learning Software; Deep Learning Software; Image Analysis Software
2) By Hardware: AI-Powered Imaging Systems; Diagnostic Devices
3) By Services: AI Integration Services; Consulting And Training Services; Support And Maintenance Services
Companies Mentioned: Microsoft Corporation; IBM Corporation; Babylon Healthcare Services Ltd.; Verily Life Sciences LLC; Tempus; Guardant Health; Lunit Inc.; Paige AI Inc.; Ada Health GmbH; Viz.ai Inc.; Butterfly Network Inc.; Insilico Medicine; BenevolentAI SA SA; Enlitic Inc.; Ibex Medical Analytics; Kheiron Medical Technologies Limited; CureMetrix Inc.; CancerIQ Inc.; MultiplAI Health; Freenome Holdings Inc.; SkinVision; Entopsis; Owkin; Imagen Technologies; Panakeia Technologies; EchoPixel Inc.; X-Zell Inc.; Cyrcadia Health; Oncora Medical; Xilis
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. AI In Cancer Diagnostics Market Characteristics

3. AI In Cancer Diagnostics Market Trends And Strategies

4. AI In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global AI In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global AI In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global AI In Cancer Diagnostics Market Growth Rate Analysis
5.4. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global AI In Cancer Diagnostics Total Addressable Market (TAM)

6. AI In Cancer Diagnostics Market Segmentation

6.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Software Solutions
Hardware
Services
6.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Breast Cancer
Lung Cancer
Brain Tumor
Skin Cancer And Cervical Cancer
Prostate And Colorectal Cancer
Other Cancer Types
6.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Screening And Diagnosis
Tumor Identification
Monitoring
6.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Medical Research Institutes
Contract Research Organizations
6.5. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Machine Learning Software
Deep Learning Software
Image Analysis Software
6.6. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
AI-Powered Imaging Systems
Diagnostic Devices
6.7. Global AI In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
AI Integration Services
Consulting And Training Services
Support And Maintenance Services

7. AI In Cancer Diagnostics Market Regional And Country Analysis

7.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Cancer Diagnostics Market

8.1. Asia-Pacific AI In Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Cancer Diagnostics Market

9.1. China AI In Cancer Diagnostics Market Overview
9.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Cancer Diagnostics Market

10.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Cancer Diagnostics Market

11.1. Japan AI In Cancer Diagnostics Market Overview
11.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Cancer Diagnostics Market

12.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Cancer Diagnostics Market

13.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Cancer Diagnostics Market

14.1. South Korea AI In Cancer Diagnostics Market Overview
14.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Cancer Diagnostics Market

15.1. Western Europe AI In Cancer Diagnostics Market Overview
15.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Cancer Diagnostics Market

16.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Cancer Diagnostics Market

17.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Cancer Diagnostics Market

18.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Cancer Diagnostics Market

19.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Cancer Diagnostics Market

20.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Cancer Diagnostics Market

21.1. Eastern Europe AI In Cancer Diagnostics Market Overview
21.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Cancer Diagnostics Market

22.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Cancer Diagnostics Market

23.1. North America AI In Cancer Diagnostics Market Overview
23.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Cancer Diagnostics Market

24.1. USA AI In Cancer Diagnostics Market Overview
24.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Cancer Diagnostics Market

25.1. Canada AI In Cancer Diagnostics Market Overview
25.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Cancer Diagnostics Market

26.1. South America AI In Cancer Diagnostics Market Overview
26.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Cancer Diagnostics Market

27.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Cancer Diagnostics Market

28.1. Middle East AI In Cancer Diagnostics Market Overview
28.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Cancer Diagnostics Market

29.1. Africa AI In Cancer Diagnostics Market Overview
29.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles

30.1. AI In Cancer Diagnostics Market Competitive Landscape
30.2. AI In Cancer Diagnostics Market Company Profiles
- 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. IBM Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Babylon Healthcare Services Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Tempus Overview, Products and Services, Strategy and Financial Analysis

31. AI In Cancer Diagnostics Market Other Major And Innovative Companies

31.1. Guardant Health
31.2. Lunit Inc.
31.3. Paige AI Inc.
31.4. Ada Health GmbH
31.5. Viz.ai Inc.
31.6. Butterfly Network Inc.
31.7. Insilico Medicine
31.8. BenevolentAI SA SA
31.9. Enlitic Inc.
31.10. Ibex Medical Analytics
31.11. Kheiron Medical Technologies Limited
31.12. CureMetrix Inc.
31.13. CancerIQ Inc.
31.14. MultiplAI Health
31.15. Freenome Holdings Inc.

32. Global AI In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

34. Recent Developments In The AI In Cancer Diagnostics Market

35. AI In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

35.1 AI In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 AI In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 AI In Cancer Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies